Does ALIROCUMAB Cause Low density lipoprotein increased? 336 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 336 reports of Low density lipoprotein increased have been filed in association with ALIROCUMAB (Praluent). This represents 1.5% of all adverse event reports for ALIROCUMAB.
336
Reports of Low density lipoprotein increased with ALIROCUMAB
1.5%
of all ALIROCUMAB reports
0
Deaths
16
Hospitalizations
How Dangerous Is Low density lipoprotein increased From ALIROCUMAB?
Of the 336 reports, 16 (4.8%) required hospitalization, and 2 (0.6%) were considered life-threatening.
Is Low density lipoprotein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALIROCUMAB. However, 336 reports have been filed with the FAERS database.
What Other Side Effects Does ALIROCUMAB Cause?
Myalgia (1,571)
Product dose omission (1,354)
Injection site pain (1,220)
Muscle spasms (1,113)
Arthralgia (993)
Fatigue (922)
Pain (892)
Pain in extremity (888)
Product dose omission issue (864)
Injection site bruising (821)
What Other Drugs Cause Low density lipoprotein increased?
EVOLOCUMAB (1,024)
INCLISIRAN (423)
ROSUVASTATIN (241)
ATORVASTATIN (217)
EZETIMIBE (217)
LOMITAPIDE (164)
TOFACITINIB (135)
FINGOLIMOD (132)
SOMATROPIN (93)
LORLATINIB (78)
Which ALIROCUMAB Alternatives Have Lower Low density lipoprotein increased Risk?
ALIROCUMAB vs ALISKIREN
ALIROCUMAB vs ALISKIREN HEMIFUMARATE
ALIROCUMAB vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALIROCUMAB vs ALIZAPRIDE
ALIROCUMAB vs ALLANTOIN